MedTrace Logo

Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

NCT04336761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 901

Last updated 2021-03-11

No results posted yet for this study

Summary

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Conditions

  • Coronavirus
  • COVID
  • Infection Viral

Interventions

DIAGNOSTIC_TEST

nasopharyngeal swab

Data collection and nasopharyngeal swab

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • François Dubos, MD,PhD · University Hospital, Lille

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04336761 on ClinicalTrials.gov